By
Drug Target Review2023-10-05T14:00:40
Researchers find genetic explanation for increased risk of developing second cancers.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-04-04T15:03:09
Sponsored by Agilent
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2024-01-24T12:52:38
Sponsored by BellBrook Labs
Site powered by Webvision Cloud